Flagship Harbor Advisors’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
PA
CS
BBA
CAM
RG
LPC
Flagship Harbor Advisors's ZYME Position: Q4 2020 in Review
Flagship Harbor Advisors sold out of Zymeworks (ZYME) in Q4 2020, closing a stake of 209 shares — an estimated $9K sold.
Flagship Harbor Advisors first reported a position in ZYME in Q1 2019 and held it in 7 quarters. The position peaked at $9K in Q3 2020. 138 funds tracked by Wall St. Rank hold ZYME as of Q4 2020.
- Flagship Harbor Advisors reported no remaining Zymeworks position as of Q4 2020 after selling out during the quarter.
- Flagship Harbor Advisors sold 209 Zymeworks shares in Q4 2020, an estimated $9K.
- Flagship Harbor Advisors first reported a position in Zymeworks in Q1 2019 and held it in 7 quarters.
- Flagship Harbor Advisors's Zymeworks position peaked at $9K in Q3 2020.
- 138 funds tracked by Wall St. Rank held Zymeworks as of Q4 2020.
Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.